//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Translational Redox Biology @TU Dresden @redoxlab.bsky.social Applied chemical biology for research and treatment of cancer and inflammation | science and teaching | she/her | 🌈🇪🇺🇦🇺🏳️‍🌈🏳️‍⚧️ scientist/woman/mother/overthinker in academia
Julia Thorn-Seshold









Loading...
Transient vascular disruption as delivery route may be useful for single-shot translational approaches, and for research applications. Thanks #BMFTR #GO-Bio & #VDI/VDE-IT for supporting the scientific process. From vascular TME modulation @lmu.de to biochemical TME dynamics @tudresden.bsky.social.
Reminder for our GBM Lunch Seminar tomorrow, April 22 at 12:30!
GBM Lunch on May 6, 2026, 12:30 Speaker: Youjun Yang (East China University of Science and Technology) Title: "Early Ferroptosis Detection Targeting Lipid Hydrogen Abstraction” Chair: @oliverthornseshold.bsky.social Organizer: Joint Study Group "Chemical Biology" #GBMLunch #ChemicalBiology
We tested a way to selectively increase delivery of nano-formulated drugs into solid tumours by disrupting their immature blood vessel system. In a syngeneic mouse model for TNBC (4T1) we combined 💊 clinically approved nano-formulated drug 💉 low-dose small molecule microtubule destabiliser (CA4P)
In principle: ✅ 2-3 fold increase in drug content inside solid tumours ✅ healthy organs not affected The catch: ❌ no consistent translation into improved therapeutic efficacy
What happened? 🎯 We made sure that all tumours were large enough to be neo-vascularised at the start of treatment ⏩ fast forward to 2nd/3rd treatment: no CA4P-dependent drug accumulation inside tumours anymore.
1mo
Proof of principle vs. translational reality check: Can we accumulate nano-formulated drugs inside solid tumours by transiently disrupting tumour vasculature? Yes, in principle, but with a translational catch 👇 #GO-Bio #BMFTR @lmu.de; #ChemBio bpspubs.onlinelibrary.wiley.com/doi/10.1111/...
Spatio-temporal dynamics of tumour vasculature are hard to predict, even in established models: rapid growth, collapse/reperfusion, normalisation... ➡️ vessel structure likely matured during tumour growth 📈 or even reactively remodeled after therapeutic intervention 💉 ❌ effectively losing our target
1mo
Out in BJP @britpharmsoc.bsky.social! Thank you and congrats to all co-authors and collaborators, especially to the three female lead authors! And shoutout to #reviewer2 for the constructive dialogue. This was peer-review as it should be!
1mo
1mo
1mo
1mo
Dear Lipid and Membrane Enthusiasts, There is only one month!! left to register and submit your abstracts for the @embo.org Workshop “Lipid Code to Life”, which will be held from September 7–11, 2026, in Dresden, Germany. Workshop program and registration page: meetings.embo.org/event/26-lip...
1mo
1mo
1mo
1mo
Julia Thorn-Seshold
BPS Publications
bpspubs.onlinelibrary.wiley.com
Background and purpose Nano-formulated chemotherapeutics prolong systemic availability of drugs and can reduce systemic toxicity, but their accumulation in solid tumours is often limited and unpredi...
Julia Thorn-Seshold
Julia Thorn-Seshold
Julia Thorn-Seshold
GBM (Gesellschaft für Biochemie und Molekularbiologie)
GBM (Gesellschaft für Biochemie und Molekularbiologie)